Cargando…

Preparation and Immune Effect of HEV ORF2 P206@PLGA Nanoparticles

The hepatitis E virus (HEV) is an important pathogen that threatens global public health. One-third of the world’s population lives in the epidemic area of HEV, causing 20 million infections and 70,000 deaths annually. In China, HEV transmission has changed from human-to-human transmission of HEV1 t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yifei, Sun, Zhenning, Li, Huopeng, Tian, Jijing, Chen, Mingyong, Liu, Tianlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878542/ https://www.ncbi.nlm.nih.gov/pubmed/35214924 http://dx.doi.org/10.3390/nano12040595

Ejemplares similares

Replication of hepatitis E virus in the ovary and promotion of oocyte apoptosis in rabbits infected with HEV-4
por: An, Junqing, et al.
Publicado: (2017)

PLGA-coated methylene blue nanoparticles for photoacoustic imaging and photodynamic/photothermal cascaded precisely synergistic therapy of tumor
por: Xu, Xiaomu, et al.
Publicado: (2022)

HEV-ORF3 Encoding Phosphoprotein Interacts With Hepsin
por: Wang, Chunyan, et al.
Publicado: (2014)

TB@PLGA Nanoparticles for Photodynamic/Photothermal Combined Cancer Therapy with Single Near-Infrared Irradiation
por: Yang, Yue, et al.
Publicado: (2021)

Antigenic Characterization of ORF2 and ORF3 Proteins of Hepatitis E Virus (HEV)
por: Pezzoni, Giulia, et al.
Publicado: (2021)

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
por: Lee, Jimin, et al.
Publicado: (2022)

Downregulation of CCL2 induced by the upregulation of microRNA-206 is associated with the severity of HEV71 encephalitis
por: Zhang, Guangyou, et al.
Publicado: (2017)

Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles
por: Du, Lixin, et al.
Publicado: (2023)

Effects of mRNA secondary structure on the expression of HEV ORF2 proteins in Escherichia coli
por: Behloul, Nouredine, et al.
Publicado: (2017)

Management of Hepatitis E Virus (HEV) Zoonotic Transmission: Protection of Rabbits against HEV Challenge following Immunization with HEV 239 Vaccine
por: Liu, Peng, et al.
Publicado: (2014)

The HEV Ventilator
por: Buytaert, J, et al.
Publicado: (2020)

A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice
por: Kui, Xiang, et al.
Publicado: (2017)

Virus Host Protein Interaction Network Analysis Reveals That the HEV ORF3 Protein May Interrupt the Blood Coagulation Process
por: Geng, Yansheng, et al.
Publicado: (2013)

High endothelial venules (HEVs) in immunity, inflammation and cancer
por: Blanchard, Lucas, et al.
Publicado: (2021)

The HEV Ventilator Proposal
por: Buytaert, J
Publicado: (2020)

Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery
por: Wu, Zhi Min, et al.
Publicado: (2012)

Preparation, Optimization and Activity Evaluation of PLGA/Streptokinase Nanoparticles Using Electrospray
por: Yaghoobi, Nasrin, et al.
Publicado: (2017)

PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters
por: Hernández-Giottonini, Karol Yesenia, et al.
Publicado: (2020)

Preparation and Efficacy of Newcastle Disease Virus DNA Vaccine Encapsulated in PLGA Nanoparticles
por: Zhao, Kai, et al.
Publicado: (2013)

The decay properties of $^{206}Hg$ and the $^{208}Pb(p,3p) ^{206}Hg$ reaction
por: Wolf, G K
Publicado: (1968)

HEV ORF3 downregulates TLR7 to inhibit the generation of type I interferon via impairment of multiple signaling pathways
por: Lei, Qingsong, et al.
Publicado: (2018)

Poly Lactic-co-Glycolic Acid-Coated Toluidine Blue Nanoparticles for the Antibacterial Therapy of Wounds
por: Xu, Xiaomu, et al.
Publicado: (2021)

Optimized Hepatitis E Virus (HEV) Culture and Its Application to Measurements of HEV Infectivity
por: Capelli, Nicolas, et al.
Publicado: (2020)

Quality by Design as a Tool in the Optimisation of Nanoparticle Preparation—A Case Study of PLGA Nanoparticles
por: Struzek, Anna-Maria, et al.
Publicado: (2023)

Expression Profiles of Hepatic Immune Response Genes in HEV Infection
por: Badshah, Yasmin, et al.
Publicado: (2023)

Effects of Particle Geometry for PLGA-Based Nanoparticles: Preparation and In Vitro/In Vivo Evaluation
por: Kaplan, Meryem, et al.
Publicado: (2023)

The High Energy Ventilator (HEV)
por: Ordan, Julien Marius
Publicado: (2020)

Detection of Serum Antibodies to Hepatitis E Virus Based on HEV Genotype 3 ORF2 Capsid Protein Expressed in Nicotiana benthamiana
por: Mazalovska, Milena, et al.
Publicado: (2017)

Ectopic Expression of Genotype 1 Hepatitis E Virus ORF4 Increases Genotype 3 HEV Viral Replication in Cell Culture
por: Yadav, Kush K., et al.
Publicado: (2021)

High Hepatitis E Virus (HEV) Seroprevalence and No Evidence of HEV Viraemia in Vietnamese Blood Donors
por: Cao, Le Chi, et al.
Publicado: (2023)

Optical projection tomography reveals dynamics of HEV growth after immunization with protein plus CFA and features shared with HEVs in acute autoinflammatory lymphadenopathy
por: Kumar, Varsha, et al.
Publicado: (2012)

Anti-CD206 antibody-conjugated Fe(3)O(4)-based PLGA nanoparticles selectively promote tumor-associated macrophages to polarize to the pro-inflammatory subtype
por: Zhou, Yun, et al.
Publicado: (2020)

Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
por: Duan, Dongyu, et al.
Publicado: (2018)

The ($d$,$p$) reaction on $^{206}$Hg
por: Kay, B, et al.
Publicado: (2016)

Immunoregulatory and Antimicrobial Activity of Bovine Neutrophil β-Defensin-5-Loaded PLGA Nanoparticles against Mycobacterium bovis
por: Liang, Zhengmin, et al.
Publicado: (2020)

Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design
por: Ghasemian, Elham, et al.
Publicado: (2013)

Preparation and Antibacterial Activity Evaluation of 18-β-glycyrrhetinic Acid Loaded PLGA Nanoparticles
por: Darvishi, Behrad, et al.
Publicado: (2015)

Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles
por: Derman, Serap, et al.
Publicado: (2015)

PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies
por: Liu, Ying, et al.
Publicado: (2017)

Preparation, Characterization, and Biological Evaluation of a Hydrophilic Peptide Loaded on PEG-PLGA Nanoparticles
por: Marinelli, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1a45jbmvma5hedf1nldggtutll